Repository logo
 

A role for class I p21-activated kinases in the regulation of the excitability of the actin cytoskeleton.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

The p21-activated kinases (PAKs) are involved in a range of functions, including the regulation of the actin cytoskeleton. However, although many PAK substrates identified have been implicated in the regulation of the actin cytoskeleton, a coherent picture of the total effect of PAK activation on the state of the actin cytoskeleton is unclear. Here, we show that, in mouse embryonic fibroblasts, inhibition of class I PAK kinase activity by small-molecule inhibitors leads to the constitutive production of the phosphoinositide phosphatidylinositol (3,4,5)-trisphosphate [PI(3,4,5)P3] on the ventral surface of the cell. The formation of patches of PI(3,4,5)P3 remodels the actin cytoskeleton and polarises the cell. From the overexpression of truncated and mutated PAK1 and PAK2 constructs, as well as an in vitro model of PAK activation, we propose that this is driven by a hyper recruitment of class I PAK and PAK-binding partners. This aberrant production of PI(3,4,5)P3 suggests that, by limiting its own recruitment, the kinase activity of class I PAKs acts to downregulate phosphoinositide 3-kinase (PI3K) activity, further highlighting class I PAKs as regulators of PI3K activity and therefore the excitability of the actin cytoskeleton.

Description

Peer reviewed: True


Acknowledgements: We are grateful to the Wolfson Light Microscopy Facility for use of the Nikon W1 spinning disk confocal (BB/V019368/1) and Zeiss LSM980 Airyscan 2 Confocal (MR/X012077/1). We would like to thank Dr Daniel Stark for feedback during the preparation of this manuscript. For the purpose of open access, we have applied a Creative Commons Attribution (CC BY) license to any author-accepted manuscript version arising from this submission.


Publication status: Published


Funder: University of Sheffield; doi: http://dx.doi.org/10.13039/501100000858

Journal Title

J Cell Sci

Conference Name

Journal ISSN

0021-9533
1477-9137

Volume Title

138

Publisher

The Company of Biologists

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0
Sponsorship
MRC (MR/V000616/1)
Wellcome Trust (101828/Z/13/Z)